Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jun-Ichi Iwao is active.

Publication


Featured researches published by Jun-Ichi Iwao.


Cellular and Molecular Life Sciences | 1978

Potentiative effects of sulfhydryl compounds on carrageenin-induced oedema in rats and relationship to their potencies as inhibitors of angiostin-converting enzyme in vivo

Tadashi Iso; Hideyasu Yamauchi; Hiroshi Suda; N. Nakajima; Kazuo Nishimura; Jun-Ichi Iwao

Carrageenin-induced oedema in rats was potentiated by oral administration of (4R)-3-[(2S)-3-mercapto-2-methylpropanoyl]-4-thiazolidinecarboxylic acid (SA291) and related sulfhydryl compounds, and the effect was closely correlated with their potencies as inhibitors of angiotensin-converting enzyme in vivo.


European Journal of Pharmacology | 1979

Potentiating mechanism of bradykinin action on smooth muscle by sulfhydryl compounds.

Tadashi Iso; Kazuo Nishimura; Masayuki Oya; Jun-Ichi Iwao

(4R)-3-[(2S)-3-Mercapto-2-methylpropanoyl]-4-thiazolidinecarboxylic acid (YS-980), a potent angiotensin I (AI) converting enzyme inhibitor, inhibited the contractile response of isolated guinea-pig ileum to AI but not to AII, while it potentiated the response to bradykinin. Other sulfhydryl compuonds also produced inhibition of AI action, and the effects were closely correlated with their potentiating activities against bradykinin action. These results suggest that it is mainly inhibition of the enzyme in the tissue which participates in the mechanism of potentiation of kinin action by YS-980.


Archive | 1986

Novel benzothiazine derivatives

Jun-Ichi Iwao; Tadashi Iso; Masayuki Oya


Journal of Medicinal Chemistry | 1990

Synthesis and Ca2+ antagonistic activity of 2-[2-[(aminoalkyl)oxy]-5-methoxyphenyl]-3,4-dihydro-4-methyl-3-oxo-2H- 1,4-benzothiazines.

Masanobu Fujita; Susumu Ito; Atsutoshi Ota; Nobuharu Kato; Koji Yamamoto; Yoichi Kawashima; Hideyasu Yamauchi; Jun-Ichi Iwao


Journal of Medicinal Chemistry | 1988

Novel calcium antagonists. Synthesis and structure-activity relationship studies of benzothiazoline derivatives.

Koji Yamamoto; Masanobu Fujita; Keizo Tabashi; Yoichi Kawashima; Eishin Kato; Masayuki Oya; Tadashi Iso; Jun-Ichi Iwao


Chemical & Pharmaceutical Bulletin | 1982

Thiol Compounds. V. Absolute Configuration and Crystal Structure of (4R)-2-(2-Hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarboxylic Acid

Masayuki Oya; Eishin Kato; Jun-Ichi Iwao; Noritake Yasuoka


Japanese Journal of Pharmacology | 1981

A NEW POTENT INHIBITOR OF CONVERTING ENZYME: (2R, 4R)-2-(2-HYDROXYPHENYL)-3-(3-MERCAPTOPROPIONYL)-4-THIAZOLIDINECARBOXYLIC ACID(SA446)

Tadashi Iso; Hideyasu Yamauchi; Hiroshi Suda; Katsuhiko Nakata; Kazuo Nishimura; Jun-Ichi Iwao


Chemical & Pharmaceutical Bulletin | 1978

New Sulfhydryl Compounds with Potent Antihypertensive Activities

Itaru Mita; Jun-Ichi Iwao; Masayuki Oya; Takehisa Chiba; Tadashi Iso


Archive | 1981

Sulfur-containing acylamino acids

Jun-Ichi Iwao; Masayuki Oya; Tadashi Iso


Archive | 1982

Ascorbic acid derivatives

Jun-Ichi Iwao; Masayuki Oya; Tadashi Iso

Collaboration


Dive into the Jun-Ichi Iwao's collaboration.

Top Co-Authors

Avatar

Masayuki Oya

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Takehisa Chiba

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors

Avatar

Eishin Kato

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors

Avatar

Toshio Baba

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Koji Yamamoto

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors

Avatar

Toshio Watanabe

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hiroshi Masuda

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Researchain Logo
Decentralizing Knowledge